Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.14
-0.10 (-0.55%)
May 29, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 320.35 | 322.67 | 283.47 | 289.21 | 618.97 | 992.58 | |
Revenue Growth (YoY) | 9.54% | 13.83% | -1.99% | -53.27% | -37.64% | 135.37% |
Cost of Revenue | 196.33 | 191.8 | 176.26 | 184.76 | 252.07 | 215.53 |
Gross Profit | 124.02 | 130.88 | 107.22 | 104.46 | 366.9 | 777.05 |
Selling, General & Admin | 166.18 | 160.04 | 124.35 | 130.47 | 149.99 | 75.17 |
Depreciation & Amortization Expenses | 8.07 | 8.03 | 7.97 | 7.85 | 6.5 | 1.71 |
Research & Development | 55.69 | 53.91 | 48.82 | 41.44 | 28.91 | 24.22 |
Other Operating Expenses | - | - | - | 120.23 | 2.98 | - |
Total Operating Expenses | 229.94 | 221.97 | 181.13 | 299.99 | 188.37 | 101.1 |
Operating Income | -105.92 | -91.1 | -73.92 | -195.53 | 178.53 | 675.95 |
Interest Income | 31.55 | 30.92 | 31.3 | 21.61 | 5.62 | - |
Interest Expense | -0.08 | -0.08 | -0.17 | -0.49 | -1.01 | - |
Other Non-Operating Income (Expense) | -9.83 | -9.77 | -9.51 | 0.32 | 0.89 | 3.73 |
Total Non-Operating Income (Expense) | 21.64 | 21.07 | 21.96 | 21.44 | 5.5 | 1.35 |
Pretax Income | -84.28 | -70.03 | -51.96 | -174.09 | 184.03 | 677.3 |
Provision for Income Taxes | -9.27 | -8.39 | -8.14 | 1.15 | 42.1 | 174.8 |
Net Income | -73.81 | -60.51 | -42.71 | -167.83 | 143.4 | 507.36 |
Minority Interest in Earnings | -1.2 | -1.12 | -1.11 | -7.41 | -1.48 | -1.13 |
Net Income to Common | -73.81 | -60.51 | -42.71 | -167.83 | 143.4 | 507.36 |
Net Income Growth | - | - | - | - | -71.74% | 136.74% |
Shares Outstanding (Basic) | 31 | 31 | 30 | 30 | 30 | 29 |
Shares Outstanding (Diluted) | 31 | 31 | 30 | 30 | 31 | 31 |
Shares Change (YoY) | 0.95% | 1.79% | 1.51% | -3.81% | -0.04% | 28.77% |
EPS (Basic) | -2.39 | -1.97 | -1.41 | -5.63 | 4.76 | 17.25 |
EPS (Diluted) | -2.39 | -1.97 | -1.41 | -5.63 | 4.63 | 16.38 |
EPS Growth | - | - | - | - | -71.73% | 83.84% |
Shares Outstanding | 28.85 | 31.08 | 30.84 | 29.65 | 29.44 | 30.16 |
Free Cash Flow | -111.41 | -124.21 | -19.26 | 4.8 | 234.75 | 514.77 |
Free Cash Flow Growth | - | - | - | -97.96% | -54.40% | 387.94% |
Free Cash Flow Per Share | -3.62 | -4.04 | -0.64 | 0.16 | 7.58 | 16.62 |
Gross Margin | 38.71% | 40.56% | 37.82% | 36.12% | 59.28% | 78.29% |
Operating Margin | -33.07% | -28.23% | -26.08% | -67.61% | 28.84% | 68.10% |
Profit Margin | -23.41% | -19.10% | -15.46% | -60.59% | 22.93% | 51.00% |
FCF Margin | -34.78% | -38.49% | -6.79% | 1.66% | 37.93% | 51.86% |
EBITDA | -81.72 | -66.97 | -48.99 | -169.39 | 211.19 | 686.96 |
EBITDA Margin | -25.51% | -20.76% | -17.28% | -58.57% | 34.12% | 69.21% |
EBIT | -105.92 | -91.1 | -73.92 | -195.53 | 178.53 | 675.95 |
EBIT Margin | -33.07% | -28.23% | -26.08% | -67.61% | 28.84% | 68.10% |
Effective Tax Rate | 11.00% | 11.99% | 15.66% | -0.66% | 22.88% | 25.81% |